Jelena Z. Milovanovic
Kragujevac, SE, Serbia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Galectin-3 Mediates Heme-Induced Multi-Organ Dysfunction by Modulating the Splenic Immune Microenvironment.
Journal: Diseases (Basel, Switzerland)
Published: March 22, 2026
Anti-Inflammatory Effects of Goat Whey Protein in Concanavalin-A Induced Hepatitis.
Journal: Nutrients
Published: January 06, 2026
The Possible Effects of Galectin-3 on Mechanisms of Renal and Hepatocellular Injury Induced by Intravascular Hemolysis.
Journal: International journal of molecular sciences
Published: June 05, 2024
Synthesis, characterization, biomolecular interactions, molecular docking, and in vitro and in vivo anticancer activities of novel ruthenium(III) Schiff base complexes.
Journal: Journal of inorganic biochemistry
Published: July 14, 2023
Docking Studies, Cytotoxicity Evaluation and Interactions of Binuclear Copper(II) Complexes with S-Isoalkyl Derivatives of Thiosalicylic Acid with Some Relevant Biomolecules.
Journal: International journal of molecular sciences
Published: July 01, 2023
The Role of IL-17 in the Pathogenesis of Oral Squamous Cell Carcinoma.
Journal: International journal of molecular sciences
Published: May 12, 2023
The Pivotal Role of Galectin-3 in Viral Infection: A Multifaceted Player in Host-Pathogen Interactions.
Journal: International journal of molecular sciences
Published: May 07, 2023
The Expression of IL-1β Correlates with the Expression of Galectin-3 in the Tissue at the Maternal-Fetal Interface during the Term and Preterm Labor.
Journal: Journal of clinical medicine
Published: September 28, 2022
The Pt(S-pr-thiosal)2 and BCL1 Leukemia Lymphoma: Antitumor Activity In Vitro and In Vivo.
Journal: International journal of molecular sciences
Published: June 17, 2022
CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings.
Journal: Current oncology (Toronto, Ont.)
Published: March 31, 2022
A new bis-pyrazolylpyridine ruthenium(III) complex as a potential anticancer drug: in vitro and in vivo activity in murine colon cancer.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: May 13, 2021
Last Updated: 09/26/2026